Crossmark

An overview of the use of cutting-edge artificial intelligence (AI) modeling to produce synthetic medical data (SMD) in decentralized clinical machine learning (ML) for ovarian cancer(OC) and ovarian lymphoma(OL)

Crossref DOI link: https://doi.org/10.1007/s40477-025-00983-3

Published Online: 2025-01-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Donatello, Diana https://orcid.org/0000-0002-1645-4678
License Information

Text and Data Mining valid from 2025-01-22

Version of Record valid from 2025-01-22
More Information

Article History

Received: 30 December 2024

Accepted: 7 January 2025

First Online: 22 January 2025

Declarations

:

: The author declares that she has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: Not applicable.

Document is current

Any future updates will be listed below